AP

Arun Panse

Active Director Director DIN 09168252
DIN 09168252 First appointment May 2021 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2021
Shareholding value •••• Premium profile

About Arun Panse

Data last updated:

Arun Panse is a Director at Ercury Lifesciences Private Limited (since 2021). The company operates in Chemicals. Ercury Lifesciences Private Limited reported revenue of ₹27,310 (FY 2022).

DIN 09168252
Primary Designation Director
Industry Chemicals
First Appointment 07 May 2021
Oldest Company Age 5 yrs
Largest company Ercury Lifesciences Private Limited · ₹27,310 (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ercury Lifesciences Private Limited U24230MP2021PTC055998
Director07 May 20212021₹27,310 (FY 2022)Active

Board colleagues of Arun Panse

Directorship timeline

Open interactive timeline →
Ercury Lifesciences Private Limited
Premium access

Shareholding and investment profile for Arun Panse

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arun Panse

Arun Panse currently holds 1 directorship: Ercury Lifesciences Private Limited (Director, since 07 May 2021, revenue ₹27,310 (FY 2022)).

Arun Panse was first appointed on 07 May 2021 as Director at Ercury Lifesciences Private Limited.

The current boards of Arun Panse's companies include Khusyal Gadekar (Ercury Lifesciences Private Limited), Umesh Kumar Barpete (Ercury Lifesciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available